Related Experiment Videos
Chemoreceptor sensitivity and maladaptation to high altitude in man
Summary
Reduced chemoreceptor sensitivity may cause altitude maladaptation syndromes like High Altitude Pulmonary Oedema (HAPO) and Acute Mountain Sickness (AMS). This study found lower sensitivity in maladapted individuals compared to acclimatized ones.
Area of Science:
- Altitude physiology
- Respiratory medicine
- Environmental health
Background:
- Altitude exposure can lead to maladaptation syndromes.
- Chemoreceptor sensitivity plays a role in physiological responses to altitude.
Purpose of the Study:
- To investigate the role of chemoreceptor sensitivity in altitude maladaptation.
- To compare chemoreceptor sensitivity between acclimatized and maladapted individuals.
Main Methods:
- Two-phase study comparing chemoreceptor sensitivity in acclimatized vs. maladapted subjects (HAPO/AMS).
- Measurements included hypoxic/CO2 sensitivity, ventilation, respiratory function, and vital signs at varying altitudes.
- Phase I conducted in Delhi, Phase II at 3,500m.
Main Results:
- Maladapted subjects exhibited significantly lower sensitivity to both hypoxia and carbon dioxide.
- This finding was consistent across different categories of maladaptation and acclimatization.
Conclusions:
- Reduced chemoreceptor sensitivity is a potential initiating factor in altitude maladaptation syndromes.
- Understanding chemoreceptor function is crucial for preventing and managing altitude sickness.